Blockade of interleukin‐6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons
Open Access
- 10 June 2005
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 94 (2) , 459-468
- https://doi.org/10.1111/j.1471-4159.2005.03227.x
Abstract
Interleukin (IL)‐6 expression transiently increases in the acute phase of cerebral ischemia. To investigate the physiological significance of endogenous IL‐6 expression and to identify the main signal pathway for the action of IL‐6, we administered anti‐mouse IL‐6 receptor monoclonal antibody (IL‐6RA), which blocks IL‐6 signaling, to mice immediately after a 45‐min period of middle cerebral artery occlusion (MCAO). At 6 h after MCAO, IL‐6RA administration had resulted in a significant reduction in the amount of phosphorylated signal transducer and activator of transcription‐3 (Stat3) protein in the peri‐infarct area of the cortex. At 24 h after MCAO, blockade of IL‐6 signaling had led to an increase in number of apoptotic cells in the peri‐infarct area and enlargement of the size of the infarct, and it had adversely affected neurological function. These results suggest that endogenous IL‐6 plays a critical role in preventing damaged neurons from undergoing apoptosis in the acute phase of cerebral ischemia and that its role may be mediated by Stat3 activation.Keywords
This publication has 48 references indexed in Scilit:
- Interleukin-6 and Stroke: Cerebral Ischemia Versus Nonspecific Factors Influencing Interleukin-6Stroke, 2003
- The release of tumor necrosis factor–α is associated with ischemic tolerance in human strokeAnnals of Neurology, 2003
- Multiple Levels of Regulation of the Interleukin-6 System in StrokeStroke, 2003
- Phosphorylation of Signal Transducer and Activator of Transcription-3 (Stat3) after Focal Cerebral Ischemia in RatsExperimental Neurology, 2001
- Proinflammatory Cytokines and Early Neurological Worsening in Ischemic StrokeStroke, 2000
- Caspases determine the vulnerability of oligodendrocytes in the ischemic brainJournal of Clinical Investigation, 2000
- Lack of Interleukin-6 Expression Is Not Protective Against Focal Central Nervous System IschemiaStroke, 2000
- Suppression of Endogenous bcl-2 Expression by Antisense Treatment Exacerbates Ischemic Neuronal DeathJournal of Cerebral Blood Flow & Metabolism, 2000
- Early Intrathecal Production of Interleukin-6 Predicts the Size of Brain Lesion in StrokeStroke, 1995
- Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.Stroke, 1986